BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SomnoMed Limited (SOM:ASX) Release: National Center for Integrated Dental Sleep Health program


6/19/2012 10:22:17 AM

FRISCO, Texas and WILMINGTON, Mass., June 18, 2012 /PRNewswire/ -- SomnoMed (ASX: SOM) and Sleep HealthCenters are pleased to announce a partnership to create the National Center for Integrated Dental Sleep Health (NCIDSH) program.

SomnoMed and Sleep HealthCenters launched a new national integrated dental sleep health program at the 21st Annual Meeting of the Academy of Dental Sleep Medicine and 26th Annual Meeting of the Associated Professional Sleep Society, LLC (APSS) in Boston last week.

The NCIDSH is a national service that will bring together SomnoMed's dental network and the Sleep Partners® network - a national network of accredited sleep health providers - to diagnose and treat patients suffering from sleep disorders, such as sleep disordered breathing. SomnoMed's dental network consists of approximately 2,000 qualified and experienced dental practices in the treatment of the SomnoDent apnea therapy. SleepPartners® is a national network of nearly 400 sleep medicine centers focused on the comprehensive disease management of sleep disorders.

NCIDSH will provide participating practices and centers with testing, treatment and compliance protocols that meet American Academy of Sleep Medicine (AASM) guidelines. Additionally, participants in the NCIDSH program gain access to a comprehensive set of clinical, operational and administrative support services, along with data analytics and on-going quality assurance and improvement activities.

"Our partnership with Sleep HealthCenters is strategically important as we build our medical department. This program properly associates dentists, sleep medicine centers and physicians in a well-defined, physician driven treatment protocol," said SomnoMed Chairman Dr. Peter Neustadt. "The focus of this program is on evidence based, quality clinical outcomes."

"We are delighted to be partnering with SomnoMed and their national network of quality dentists," said Sleep HealthCenters CEO Paul Valentine. "Sleep HealthCenters is committed to helping these important healthcare providers effectively integrate sleep medicine into their practices to enable clinically-validated screening, diagnosis and treatment services for individuals suffering from sleep disorders."

About Sleep HealthCenters

Sleep HealthCenters is a network of specialized sleep medicine centers accredited by the American Academy of Sleep Medicine (AASM) and staffed by board-certified sleep specialists. Sleep HealthCenters' specialized sleep labs, clinics and programs provide all the required services needed to screen, diagnose, treat and support patients with sleep disorders. These integrated services enable Sleep HealthCenters to offer patients, employers, referring providers and managed care organizations greater convenience, valuable information and better outcomes.

About SomnoMed

SomnoMed is a public company providing diagnostic and treatment solutions for Sleep-related Breathing Disorders including obstructive sleep apnea, snoring and bruxism. SomnoMed was commercialized on the basis of extensive clinical research. Supporting independent clinical research, continuous innovation and instituting medical manufacturing standards has resulted in SomnoDent® becoming the state-of-the-art and clinically proven medical oral appliance therapy for obstructive sleep apnea. SomnoDent® is the most comfortable and effective design and treatment solution for over 100,000 patients in 22 countries.

Contact: Anthony White, 888-447-6673, awhite@somnomed.com

SOURCE SomnoMed



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES